CDK9/cyclin T1: a host cell target for antiretroviral therapy

Author： Klebl Bert M   Choidas Axel  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.1, Iss.3, 2006-05, pp. : 317-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target

By  

Current Pharmaceutical Design, Vol. 18, Iss. 20, 2012-07 ,pp. : 2883-2890

Bentham Science Publishers

Access to resources Recommend Favorite

The HIV-1 Nef protein as a target for antiretroviral therapy

By Coleman S.H.   Day J.R.   Guatelli J.C.  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 1, 2001-02 ,pp. : 1-22

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 Integration as a Target for Antiretroviral Therapy: A Review

By  

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 2, 2001-08 ,pp. : 133-149

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents

By  

Current Medicinal Chemistry, Vol. 22, Iss. 2, 2014-12 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite

The HIV-1 Nucleocapsid Zinc Finger Protein as a Target of Antiretroviral Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 15, 2004-11 ,pp. : 1605-1622

Bentham Science Publishers

Access to resources Recommend Favorite